1558Clinico-demographic Profile and Treatment Outcomes of Pediatric Participants of a Large Outpatient HIV Clinic in Kigali, Rwanda
نویسندگان
چکیده
Background. Pediatric patients make up 7.5% of the global population living with HIV infection and comprise 15% of incident cases worldwide each year (WHO). 91% of the 3.4 million children living with HIV at the end of 2011 reside in sub-Saharan Africa (WHO). They represent a challenging population to manage due to limited pediatric ARV formulations, poor healthcare resources, suboptimal medication adherence, societal stigma and neglect. Data on the demographics, clinical profile, and treatment outcomes of the pediatric HIV population is lacking in Rwanda. Methods. Study was a retrospective chart review conducted from February 1, 2013 – January 31, 2014. The aim was to describe the demographics, clinical characteristics, and treatment outcomes of HIV infected pediatric participants (age <18 years) of a large outpatient HIV clinic in Kigali, Rwanda. Charts for review were selected by simple random sampling. Categorical demographic data and other categorical variables were expressed as simple frequencies and/or percentages of the whole. Continuous variables were expressed as median values with inter-quartile ranges or means with ranges as appropriate. Results. 174 randomly selected charts were reviewed including 84 males and 90 females (sex distribution 1:1.1). Median age and CD4 count at the time of HIV diagnosis was 6 years (IQR 3-9 years) and 380 cells/uL (IQR 206-662 cells/uL) respectively. Nadir CD4 count was 272 cells/uL (IQR 148-416 cells/uL). Vertical transmission was the predominant mode of acquisition of HIV infection (70%). 46 out of 161 patients (28.6%) had WHO clinical stage 3 or 4 HIV disease at time of initial presentation to care. 68.2%, 27.2% and 4.6% of patients were on nevirapine (NVP), efavirenz(EFV) and lopinavir/ritonavir based regimens respectively. Average duration of ARV exposure was 83 months (range 8-135 months). 61/162 patients (37.7%) had HIV viral loads >400 copies/ml during their most recent viral load estimation. Conclusion. Pediatric participants of the largest outpatient HIV clinic in Kigali, Rwanda frequently present late to care with advanced HIV disease and experience significant rates of virologic failure. More studies are needed to explore the causes of these observations. Disclosures. All authors: No reported disclosures.
منابع مشابه
Improving Prevention of Mother-to-Child Transmission of HIV Care and Related Services in Eastern Rwanda
1 Department of Pediatrics, Dartmouth Medical School, Hanover, New Hampshire, United States of America, 2 Dartmouth Medical School, Hanover, New Hampshire, United States of America, 3 Partners in Health-Rwanda, Kigali, Rwanda, 4 Brigham and Women’s Hospital, Boston, Massachusetts, United States of America, 5 Harvard Medical School, Boston, Massachusetts, United States of America, 6 Division of ...
متن کاملImplementation Research: An Efficient and Effective Tool to Accelerate Universal Health Coverage
Success in the implementation of evidence-based interventions (EBIs) in different settings has had variable success. Implementation research offers the approach needed to understand the variability of health outcomes from implementation strategies in different settings and why interventions were successful in some countries and failed in others. When mastered and embedd...
متن کاملEbola Treatment and Prevention are not the only Battles: Understanding Ebola-related Fear and Stigma
متن کامل
Molecular and Phylogeographic Analysis of Human Immuno-deficiency Virus Type 1 Strains Infecting Treatment-naive Patients from Kigali, Rwanda
This study aimed at describing the genetic subtype distribution of HIV-1 strains circulating in Kigali and their epidemiological link with the HIV-1 strains from the five countries surrounding Rwanda. One hundred and thirty eight pol (RT and PR) sequences from 116 chronically- and 22 recently-infected antiretroviral therapy (ART)-naïve patients from Kigali were generated and subjected to HIV dr...
متن کاملLow Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda
Treatment outcomes of HIV patients receiving antiretroviral therapy (ART) in Rwanda are scarcely documented. HIV viral load (VL) and HIV drug-resistance (HIVDR) outcomes at month 12 were determined in a prospective cohort study of antiretroviral-naïve HIV patients initiating first-line therapy in Kigali. Treatment response was monitored clinically and by regular CD4 counts and targeted HIV vira...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 1 شماره
صفحات -
تاریخ انتشار 2014